Filing Flows › Comparisons › CELU vs QURE
Celularity vs uniQure N.V.: CELU and QURE compared
Celularity is the larger company: $5.4M of revenue in its latest quarter (Q2 2026) against $5.2M for uniQure N.V. (Q3 2026). uniQure N.V. is growing faster (+40% against -5% a year earlier).
Where the money goes: CELU and QURE
Celularity (CELU) · Q2 2026
Celularity, Q2 2026: revenue $5.4M (-5% year over year), operating margin -78.0%, net earnings $706K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
uniQure N.V. (QURE) · Q3 2026
uniQure N.V., Q3 2026: revenue $5.2M (+40% year over year), net loss $61.2M, operating cash flow −$47.8M. The chart follows the revenue to costs, profit and cash.
| Celularity (CELU) | uniQure N.V. (QURE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $5.4M | $5.2M |
| Revenue growth, Y/Y | -5% | +40% |
| Operating margin | -78.0% | n/m |
| Net earnings | $706K | −$61.2M |
| Net margin | 13.0% | — |
| Operating cash flow | −$1.1M | −$47.8M |
Where the revenue comes from
Celularity
- Product: $4.1M (75%)
- License Royalty and Other: $719K (13%)
- Service: $652K (12%)
Questions
Which is bigger, Celularity or uniQure N.V.?
Celularity is the larger company: $5.4M of revenue in its latest quarter (Q2 2026) against $5.2M for uniQure N.V. (Q3 2026).
Is Celularity or uniQure N.V. growing faster?
uniQure N.V. is growing faster (+40% against -5% a year earlier).
More: Celularity earnings · how Celularity makes money · uniQure N.V. earnings · how uniQure N.V. makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 20, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.